STRs in panel
Prev Next

Growth failure in early childhood

Gene: RASA2

Amber List (moderate evidence)

RASA2 (RAS p21 protein activator 2)
EnsemblGeneIds (GRCh38): ENSG00000155903
EnsemblGeneIds (GRCh37): ENSG00000155903
OMIM: 601589, Gene2Phenotype
RASA2 is in 4 panels

3 reviews

Catherine Snow (Genomics England)

The rating of this gene has been updated to AMBER and the mode of inheritance set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown following NHS Genomic Medicine Service approval.
Created: 31 Jan 2023, 5:28 p.m. | Last Modified: 31 Jan 2023, 5:28 p.m.
Panel Version: 2.33

Arina Puzriakova (Genomics England Curator)

Comment on list classification: Three unrelated cases reported to date (PMID: 25049390) but very limited details and no segregation data. Not associated with any phenotype in OMIM or G2P, and rated LIMITED by ClinGen. Rating Amber, awaiting additional publications/clinical evidence to corroborate causality.
Created: 6 Jan 2023, 10:29 a.m. | Last Modified: 6 Jan 2023, 10:29 a.m.
Panel Version: 2.22

Eleanor Williams (Genomics England Curator)

Review submitted on behalf of Helen Storr. Mode of inheritance: AD. Phenotypes: 15 RASopathy genes are already included in the panel. These cause a range of clinical features within the Noonan syndrome / overlapping RASopathy spectrum disorders. >80% children with NS have growth failure. It is a multi-system disorder with several other important features that need to be identified/screened for including cardiac disease, cancer susceptibility, developmental problems and learning difficulties. The panel needs to updated to reflect the expanding gene list causing RASopathies. Publications: Although RASopathy genes are included on this panel, this needs to be updated / expanded with more newly identified genes and in line with current guidance (recent review - Zenker et al, Arch Dis Child 2022). Mechansim: Dysregulation of RAS-MAPK pathway with concomitant impact on growth and GH signalling. Penetrance: Variable penetrance depending on the gene - some unclear.
Created: 22 Dec 2022, 11:07 a.m. | Last Modified: 22 Dec 2022, 11:07 a.m.
Panel Version: 2.5

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • NHS GMS
  • Expert Review Amber
  • Expert list
Phenotypes
  • Noonan syndrome
OMIM
601589
Clinvar variants
Variants in RASA2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

31 Jan 2023, Gel status: 2

Added New Source

Catherine Snow (Genomics England)

Source NHS GMS was added to RASA2.

6 Jan 2023, Gel status: 2

Set publications

Arina Puzriakova (Genomics England Curator)

Publications for gene: RASA2 were set to

6 Jan 2023, Gel status: 2

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: rasa2 has been classified as Amber List (Moderate Evidence).

6 Jan 2023, Gel status: 1

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: RASA2 were changed from to Noonan syndrome

6 Jan 2023, Gel status: 1

Set mode of inheritance

Arina Puzriakova (Genomics England Curator)

Mode of inheritance for gene: RASA2 was changed from to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

22 Dec 2022, Gel status: 1

Created, Added New Source, Set mode of inheritance

Eleanor Williams (Genomics England Curator)

gene: RASA2 was added gene: RASA2 was added to Growth failure in early childhood. Sources: Expert list Mode of inheritance for gene: RASA2 was set to